The future of cancer care starts here.

Hope without Harm

Most precision cancer drugs chase genetic alterations. We attack how tumors survive.

about-img
About Avesta

Transforming Research Into Real-World Impact

Avesta is a science-driven organization committed to advancing cancer treatments, human health, and longevity through rigorous research, ethical innovation, and a relentless focus on patient outcomes.

We bridge the gap between scientific discovery and human healing – guided by one belief: the most powerful medicine heals without harm. As we advance toward first-in-human clinical trials, we carry that conviction from the laboratory to the patients who need it most.

Evidence-Based Patient-Centered Ethically Driven
14+
Advisor-Credited FDA Approvals
$35M
in Grant Funding
16,500+
Citations
Our Foundation

Where Science Meets Humanity

01
avesta-emblem-science-microscope

Science

Evidence-driven innovation built on rigorous methodology and unwavering scientific integrity.

02
avesta-emblem-patients-heart

Patients

Human-centered outcomes placing the lived experience of patients at the heart of every decision.

03
avesta-emblem-research-data

Research

Data-backed advancement translating clinical insights into actionable therapies and improvements.

04
avesta-emblem-founded-seedling

Philanthropy

Creating meaningful change through philanthropic engagement, public health education, and community partnerships.

Our Focus Areas

Where We Direct Our Science

Six domains where Avesta’s research creates deep and lasting impact on human health.

oncology

Oncology

Developing targeted therapies that confront cancer at its source while sparing healthy tissue.

rare-disease

Rare Disease

Pursuing treatments for overlooked conditions where patients have waited too long for effective options.

metabolic-diseases

Metabolic Diseases

Addressing the underlying biology of metabolic dysfunction to restore balance and bring lasting health.

Chronic Inflammatory Diseases

Chronic Inflammatory Diseases

Targeting the persistent inflammation that drives chronic illness and erodes quality of life.

Neurological Diseases

Neurological Diseases

Advancing therapies for complex conditions of the brain and nervous system where effective options remain scarce.

AI-Driven Discovery

AI-Driven Discovery

Harnessing artificial intelligence to uncover novel therapeutic targets, accelerate the discovery of new medicines, and improve patient outcomes.

Our Journey

Impact Milestones

Background Science
Background Science
Foundational Discovery

Years of rigorous research uncovered a new approach to healing the body without harming it.

Founded
Founded
Organization Established

Avesta founded on the principle that science must serve humanity without compromise.

Partnerships
Partnerships
Strategic Collaborations

Alliances with leading institutions accelerate the path from discovery to patients.

Global Expansion
Future
Global Expansion

Advancing our therapies into Phase I clinical trials across the world to bring treatments to patients everywhere.

Research Spotlight
Featured-Research
πŸ”¬ Featured Research

RLIP76: Confronting Cancer at Its Source

RLIP76 is a stress-survival protein that cancer cells depend on to evade the body’s natural defenses and resist treatment. Depleting RLIP76 is intended to restore the body’s own anti-cancer signaling, while the same biology points toward broader benefits for metabolic health, resilience, and healthy aging.

Explore the Science β†’
Our People

The Team Behind the Mission

Leadership Team
Ian Akash Morrison

Ian Akash Morrison

CEO & Co-Founder
Sanjay Awasthi

Sanjay Awasthi, M.D.

Chief R&D Officer & Co-Founder
Arjun Awasthi

Arjun Awasthi, Ph.D.

COO & Co-Founder
Wayne Klohs

Wayne Klohs, Ph.D.

Director, Oncology Drug Development
Natasha Moor

Natasha Moor

Chief Communications Officer
Sam Meredith

Sam Meredith

VP of Global Business Development
John Stillson

John Stillson

Financial Controller
Scientific & Medical Advisory Team
Yogesh Awasthi

Yogesh Awasthi, Ph.D.

Head of Scientific Advisory Board
William Boyle

William James Boyle, Ph.D.

Board Member
Deepak Srivastava

Deepak Srivastava, M.D.

Alexander-Bridges

Alexander Bridges, Ph.D.

Sangeeta Awasthi

Sangeeta Awasthi, M.D.

Richard Carter

Richard Carter, D.O.

Uzma Naeem

Uzma Naeem, M.D.

Marcelo Vasquez

Marcelo Vasquez, M.D., Ph.D.

Jennifer Murphy

Jennifer Murphy, Ph.D.

Jacqueline Williams, Ph.D.

Business & Regulatory Advisory Team
Cambria Alpha-Cobb

Cambria Alpha-Cobb, J.D., Ph.D.

Chris-Bemben

Chris Bemben, MBA

Fran-Lambetecchio

Fran Lambetecchio

Kimberly Schofield

Kimberly Schofield

Philosophy-img
Our Philosophy

Creating Better Outcomes Through Responsible Innovation

Every study we conduct, every partnership we form, every policy we champion is guided by one enduring commitment: hope and healing must never come at the cost of harm.

Join Our Mission
Get Involved

Join Us In Building A Future Of Hope Without Harm

Whether you’re a researcher, clinician, philanthropist, or patient advocate β€” there’s a place for your expertise in Avesta’s mission.